Zimmer Biomet Income Statement
ZBH / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Zimmer Biomet reported $8.2B in revenue and $705M in net income for FY2025. Revenue has grown at a 5.1% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.2B | $7.7B | $7.4B | $6.9B | $6.8B | $6.1B | $7.8B | $7.7B | $7.8B | $4.7B | $6.0B | $4.7B | $4.6B | $4.2B | $4.1B |
| Cost of Revenue | $2.5B | $2.2B | $2.1B | $2.0B | $2.0B | $1.8B | $2.1B | $2.4B | $2.1B | $1.2B | $1.8B | $1.2B | $1.3B | $1.0B | $990.7M |
| Gross Profit | - | - | - | - | - | - | $1.3B | $1.3B | $1.3B | $1.1B | $829.1M | $856.1M | $3.3B | $3.2B | $3.1B |
| SG&A Expense | $3.3B | $2.9B | $2.8B | $2.8B | $2.8B | $2.7B | $3.1B | $2.9B | $3.1B | $1.8B | $2.3B | $1.8B | $1.7B | $1.8B | $1.7B |
| R&D Expense | $458.5M | $437.4M | $458.7M | $406.0M | $435.8M | $322.8M | $369.9M | $365.6M | $369.9M | $187.4M | $268.8M | $187.4M | $203.0M | $218.5M | $205.7M |
| Operating Income | $1.1B | $1.3B | $1.3B | $696.3M | $860.3M | $83.1M | $799.3M | $821.1M | $799.3M | $1.0B | $467.3M | $1.0B | $1.1B | $916.7M | $1.0B |
| Interest Expense | -$292.8M | - | - | - | - | - | -$325.3M | -$355.0M | $327.5M | $63.1M | $286.6M | $63.1M | $70.1M | $60.2M | $22.4M |
| Income Tax | $125.7M | $131.4M | $42.2M | $112.3M | $53.5M | -$96.0M | -$1.3B | $95.0M | -$1.3B | $220.2M | $7.0M | $220.2M | $229.5M | $263.3M | $280.8M |
| Net Income | $705.1M | $903.8M | $1.0B | $231.4M | $401.6M | -$138.9M | $1.8B | $305.9M | $1.8B | $720.3M | $147.0M | $720.3M | $780.4M | $596.9M | $717.4M |
| EPS (Basic) | $3.56 | $1.10 | $1.93 | -$0.67 | $5.52 | -$1.86 | $8.98 | $1.53 | $0.78 | $4.26 | $4.60 | $4.32 | $4.05 | $2.98 | $3.34 |
| EPS (Diluted) | $3.55 | $1.10 | $1.91 | -$0.67 | $5.47 | -$1.86 | $8.90 | $1.51 | $0.77 | $4.20 | $4.54 | $4.29 | $4.03 | $2.97 | $3.32 |
| Shares Outstanding | 198.7M | 210.3M | 210.4M | 207.0M | 206.7M | 203.5M | 203.7M | 202.4M | 189.8M | 171.7M | 171.8M | 176.0M | 188.7M | 201.1M | 215.8M |
| Gross Margin | - | - | - | - | - | - | 16.4% | 16.8% | 16.8% | 24.3% | 13.8% | 18.3% | 72.2% | 76.0% | 75.8% |
| Operating Margin | 13.3% | 16.7% | 17.3% | 10.0% | 12.6% | 1.4% | 10.2% | 10.7% | 10.2% | 22.2% | 7.8% | 22.2% | 23.1% | 21.7% | 24.9% |
| Profit Margin | 8.6% | 11.8% | 13.9% | 3.3% | 5.9% | -2.3% | 23.2% | 4.0% | 23.2% | 15.4% | 2.5% | 15.4% | 16.9% | 14.1% | 17.5% |